Home › Glycogen Storage Disease Type II › Ohio › Cincinnati
Glycogen Storage Disease Type II clinical trials in Cincinnati, OH
3 studies for Glycogen Storage Disease Type II are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
RecruitingPhase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Pompe Disease Registry Protocol
RecruitingObservational study
- University of Cincinnati Medical Center- Site Number : 840124, Cincinnati
A Global Prospective Observational Registry of Patients With Pompe Disease
RecruitingObservational study
- University of Cincinnati Medical Center, Cincinnati
- Cincinnati Children's Hospital, Cincinnati
Glycogen Storage Disease Type II trials in other cities
- Durham, NC8 studies
- Irvine, CA5 studies
- Arlington, VA5 studies
- St. Louis, MO5 studies
- Pittsburgh, PA4 studies
- Philadelphia, PA4 studies
- New York City, NY4 studies
- Atlanta, GA4 studies
- Phoenix, AZ3 studies
- Jacksonville, FL3 studies
- Indianapolis, IN3 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer35 studies
- Cancer (all types)28 studies
- Breast Cancer25 studies
- Heart Failure24 studies
- Colorectal Cancer21 studies
- Obesity20 studies
- Metastatic Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Lung Cancer19 studies
- Ovarian Cancer19 studies
- Prostate Cancer18 studies
- Melanoma17 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.